"Dermatology clinics, research and education"

During the past decade, Skin Health Institute Inc. conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 22 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skin Health Institute Inc." #1 sponsor was "Pfizer" with 12 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Peplin" with 3 trials sponsored and "ASLAN Pharmaceuticals" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skin Health Institute Inc." #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celtaxsys Aus Pty Limited" with 1 trials as a collaborator and "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Skin Health Institute Inc." are "Atopic Dermatitis" (10 trials), "Psoriasis" (8 trials), "Alopecia Areata" (5 trials), "Dermatitis, Atopic" (4 trials) and "Acne Vulgaris" (3 trials). Many other conditions were trialed in "Skin Health Institute Inc." in a lesser frequency.

Most popular intervention types in "Skin Health Institute Inc." are "Drug" (38 trials), "Biological" (4 trials), "Other" (4 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Baricitinib" (3 trials), "Guselkumab" (3 trials), "Lebrikizumab" (3 trials) and "PEP005" (3 trials). Other intervention names were less common.

The vast majority of trials in "Skin Health Institute Inc." are 42 trials for "All" genders.

Currently, there are NaN active trials in "Skin Health Institute Inc.". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Skin Health Institute Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Skin Health Institute Inc., 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".